In this episode of the Virtual Breakfast Series, we are joined by James Peyer and Juliette Han, the CEO and COO, respectively, of Cambrian Biopharma. Cambrian is focused on the basic biology of aging, also known as geroscience, and on developing therapeutics that target biological hallmarks of aging. The company completed a $100MM Series C round in 2021 and was a presenter at our Emerging Company Showcase at the New York Stock Exchange in December 2-21